IllnessHaemochromatosis, differential diagnosis
Summary
Comprehensive differential diagnostic panel for Hemochromatosis comprising 1 guideline-recommended core gene and altogether 11 curated genes according to the clinical signs
15,8 kb (Extended panel: incl. additional genes)
- EDTA-anticoagulated blood (3-5 ml)
NGS + SNP
[Sanger]
Gene panel
Selected genes
Name | Exon Length (bp) | OMIM-G | Referenz-Seq. | Heredity |
---|---|---|---|---|
BMP6 | 1549 | NM_001718.6 | AD | |
CP | 3198 | NM_000096.4 | AR | |
HAMP | 255 | NM_021175.4 | AR | |
HFE | 1047 | NM_000410.4 | AR | |
HJV | 1281 | NM_213653.4 | AR | |
SLC40A1 | 1716 | NM_014585.6 | AD | |
TFR2 | 2406 | NM_003227.4 | AR | |
BMP2 | 1191 | NM_001200.4 | n.k. | |
CYBRD1 | 474 | NM_001127383.2 | AR | |
FTH1 | 552 | NM_002032.3 | AD | |
TF | 2097 | NM_001063.4 | AR |
Informations about the disease
Hereditary haemochromatosis is mostly caused by biallelic mutations in the HFE gene. HFE-associated hemochromatosis is characterised by excessive iron storage in the liver, skin, pancreas, heart, joints and anterior pituitary gland. Early symptoms in untreated individuals include abdominal pain, weakness, lethargy, weight loss, arthralgia, diabetes mellitus and increased risk of liver cirrhosis if serum ferritin is higher than 1000 ng/ml. Other findings may include a progressive increase in skin pigmentation, heart failure and/or arrhythmias, arthritis as well as hypogonadism. The onset of the disease is usually between the ages of 40 and 60. Differential diagnoses are juvenile hereditary haemochromatosis (HJV, HAMP), TFR2-associated haemochromatosis, SCL40A1- and BMP6-associated iron overload and acoeruloplasminaemia. HFE haemochromatosis is predominantly recessively inherited with low penetrance regarding clinical symptoms of iron overload. The other forms of hemochromatosis usually follow also autosomal recessive inheritance.
Reference: https://www.ncbi.nlm.nih.gov/books/NBK1440/
- Alias: Iron overload disease
- Allelic: Alzheimer disease, susceptibility to (HFE)
- Allelic: Brachydactyly, type A2 (BMP2)
- Allelic: Cerebellar ataxia (CP)
- Allelic: Hypoceruloplasminemia, hereditary (CP)
- Allelic: Microvascular complications of diabetes 7 (HFE)
- Allelic: Porphyria cutanea tarda, susceptibility to (HFE)
- Allelic: Porphyria variegata, susceptibility to (HFE)
- Allelic: Short stature, facial dysmorphism, skeletal anomalies with/-out cardiac anomalies (BMP2)
- Allelic: Transferrin serum level QTL2 (HFE)
- Atransferrinemia (TF)
- HFE hemochromatosis, modifier of (BMP2)
- Hemochromatosis, type 2A (HJV)
- Hemochromatosis, type 2B (HAMP)
- Hemochromatosis, type 3 (TFR2)
- Hemochromatosis, type 4 (SLC40A1)
- Hemochromatosis, type 5 (FTH1)
- Hemochromatosis, type 5 [ORPHA:447792] (BMP6)
- Hemochromatosis/HFE1 (HFE)
- Hemosiderosis, systemic, due to aceruloplasminemia (CP)
- AD
- AR
- n.k.
- Multiple OMIM-Ps
Bioinformatics and clinical interpretation
No text defined